High-Demand for Anti-Anxiety Medicines in India
Anxiety is a disorder in which a person loses his mind and cannot think wisely. Many patients in India are anxious every day and therefore looking for better medicines. According to the latest report, the total amount of USD 18.3 billion is forecast for 2025 for anxiety disorder and depression globally. The increasing prevalence of depression globally is expected to accelerate demand growth in the coming years. Prone to depression, the geriatric demographic contributes to the growing market for antidepressant products. The following are points that show that the best option is to invest in the pharmaceutical franchise of PCD anxiolytic drugs: This is currently the highest revenue share in the antidepressant market. By 2025, $ 18.3 billion in depression and anxiety disorders. Increased public awareness and increased disposable family income also help improve anti-anxiety medications.
No comments:
Post a Comment